Skip to main content

Medicinova Inc

MNOV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001226616

In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Medicinova Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of MNOV: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders35350
Shares6.96M6.85M−116.1K (−1.7%)
Value$17.6M$14.9M−$2.76M (−15.7%)

New holders (1)

Institutions that held Medicinova Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to MNOV in Q3 2022
InstitutionSharesValue% of portfolio
Buckingham Strategic Partners10,000$22.0K0.00%

Sold out (1)

Institutions that held Medicinova Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of MNOV in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Bailard, Inc.17,507$44.0K